JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shuttleworth, T. J.
Right arrow Articles by Thompson, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shuttleworth, T. J.
Right arrow Articles by Thompson, J. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 44, 31174-31178, October 29, 1999


Discriminating between Capacitative and Arachidonate-activated Ca2+ Entry Pathways in HEK293 Cells*

Trevor J. ShuttleworthDagger and Jill L. Thompson

From the Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have recently questioned whether the capacitative or store-operated model for receptor-activated Ca2+ entry can account for the influx of Ca2+ seen at low agonist concentrations, such a those typically producing [Ca2+]i oscillations. Instead, we have identified an arachidonic acid-regulated, noncapacitative Ca2+ entry mechanism that appears to be specifically responsible for the receptor-activated entry of Ca2+ under these conditions. However, it is unclear whether these two systems reflect the activity of distinct entry pathways or simply different mechanisms of regulating a common pathway. We therefore used the known selectivity of the Ca2+-stimulated type VIII adenylyl cyclase for Ca2+ entry occurring via the capacitative pathway (Fagan, K. A., Mahey, R., and Cooper, D. M. F. (1996) J. Biol. Chem. 271, 12438-12444) to attempt to discriminate between these two entry mechanisms in HEK293 cells. Consistent with the earlier reports, we found that thapsigargin induced an approximate 3-fold increase in adenylyl cyclase activity that was unrelated to global changes in [Ca2+]i or to the release of Ca2+ from internal stores but was specifically dependent on the induced capacitative entry of Ca2+. In marked contrast, the arachidonate-induced entry of Ca2+ completely failed to affect adenylyl cyclase activity despite producing a substantially greater rate of entry than that induced by thapsigargin. These data demonstrate that the arachidonate-activated entry of Ca2+ occurs via an entirely distinct influx pathway.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The agonist-stimulated entry of extracellular Ca2+ plays a critical role in the generation and maintenance of intracellular Ca2+ ([Ca2+]i)1 signals resulting from activation of receptors coupled to the phospholipase C/inositol trisphosphate signaling pathway. However, in nonexcitable cells, the precise nature and mechanism of activation of such Ca2+ entry pathways remains unclear. An activation of a Ca2+ entry that is dependent on and subsequent to the emptying of intracellular agonist-sensitive Ca2+ stores has been demonstrated in a wide variety of cells. This so-called "capacitative" or store-operated mechanism of Ca2+ entry first proposed by Putney (1, 2) appears to be an almost universal feature of cells and can be readily demonstrated to be responsible for the sustained elevations of [Ca2+]i following activation of cells with high agonist concentrations, as well as for the refilling of the agonist-sensitive stores on the termination of such signals. Recently however, we have questioned whether the demonstrated properties of such capacitative entry and the characteristics of the channels involved (as far as is currently known) are adequate or appropriate to account for the receptor-activated influx of Ca2+ seen at low agonist concentrations, such a those that typically give rise to oscillatory [Ca2+]i signals (3, 4). This is an important question for two reasons. First, it is generally considered that such oscillatory [Ca2+]i signals are likely to represent the physiologically relevant response for many cells. Second, it is known that the receptor-activated influx of Ca2+ during such signals has a marked effect on the oscillation frequency (5-9), which is a key component of the agonist-generated message within the cell. Our studies on the mechanism of Ca2+ entry during [Ca2+]i oscillations led us to the identification of a novel noncapacitative Ca2+ entry pathway that is gated by arachidonic acid and that appears to be specifically responsible for the receptor-activated entry of Ca2+ under these conditions (10, 11). Together, our studies have shown that 1) arachidonic acid is generated at the relevant agonist concentrations that are known to produce [Ca2+]i oscillations in the same cells; 2) the addition of low concentrations of exogenous arachidonic acid induces an entry of Ca2+ that is entirely independent of store depletion; 3) the inhibition of the agonist-induced generation of arachidonic acid specifically and rapidly blocks the Ca2+ entry associated with [Ca2+]i oscillations, yet it is without effect on capacitative Ca2+ entry; 4) inhibition of the metabolism of arachidonic acid converts agonist-induced oscillatory [Ca2+]i signals into sustained "plateau" signals, as might be expected if Ca2+ entry was further increased by the accumulating arachidonic acid (10, 11). Based on these findings, it is our contention that arachidonic acid fulfills all the generally accepted criteria for being the second messenger responsible for the regulation of the agonist-activated entry of Ca2+ during [Ca2+]i oscillations.

What is not entirely clear, however, is whether arachidonic acid is regulating an entirely distinct Ca2+ entry pathway in the plasma membrane or merely modulating the activity of the same pathway activated by store depletion in the capacitative mechanism. We have previously shown that the [Ca2+]i signal produced by capacitative Ca2+ entry and that produced by the addition of exogenous arachidonic acid demonstrate differences in their sensitivity to a reduction in extracellular pH, suggesting that they may represent distinct entry pathways (11). In the following study, we have used the reported marked selectivity of certain Ca2+-sensitive adenylyl cyclases in cells for Ca2+ entering specifically via the capacitative pathway (12). It has been shown in a variety of studies that these adenylyl cyclases, whether endogenously present or following their transient transfection, are largely unresponsive to changes in [Ca2+]i resulting from Ca2+ release from internal stores or from Ca2+ entry via "nonspecific" ionomycin-induced pathways. In contrast, these same adenylyl cyclases are acutely sensitive to the Ca2+ entering via store-operated mechanisms (13), a sensitivity that is believed to reflect a specific co-localization of the adenylyl cyclase with the store-operated Ca2+ channels in the plasma membrane (14). In this study we have utilized the type VIII Ca2+-stimulated adenylyl cyclase transiently transfected into HEK293 cells. This is the same adenylyl cyclase and cell line used by Fagan et al. (13) who showed that its activity was markedly and specifically increased by Ca2+ entering via the capacitative or store-operated pathway.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Thapsigargin, arachidonic acid, isobutylmethylxanthine, and 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone were all from Biomol Research Laboratories Inc. The cyclic AMP binding assay kits were from Amersham Pharmacia Biotech. Samples of the human embryonic kidney cell line HEK293 were obtained from the ATCC.

Plasmid Construction and Transient Transfection-- The rat type VIII adenylyl cyclase cDNA clone in the pcDNA3.1 expression vector (Invitrogen) was generously provided by Dr. Dermot Cooper (University of Colorado, Denver, CO). HEK293 cells were cultured under standard conditions in Dulbecco's modified Eagle's medium supplemented with 10% calf serum and antibiotics at 37 °C in a humidified atmosphere of 95% air and 5% CO2. Prior to transfection, cells were seeded into 75-cm2 flasks and grown until approximately 50% confluent. Transfection was performed by the calcium phosphate method of Chen and Okayama (15) using 26 µg of plasmid DNA. Eighteen hours after transfection, cells were washed and then harvested using Ca2+-Mg2+-free phosphate-buffered saline containing 0.06% EDTA. The harvested cells were centrifuged, resuspended in medium, plated into 6-well culture dishes, and incubated for a further 2 days before experiments were performed.

Cyclic AMP Accumulation-- Adenylyl cyclase activity in vivo was assayed indirectly by determining the accumulation of cAMP in cells preincubated for 10 min in the presence of the phosphodiesterase inhibitors (500 µM isobutylmethylxanthine, 100 µM 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone). By eliminating the metabolism of generated cAMP, these inhibitors allowed an estimate of overall adenylyl cyclase activity in the intact cells. Furthermore, the use of phosphodiesterase inhibitors eliminated any possible influence of changes in [Ca2+]i affecting cAMP levels as a result of influencing phosphodiesterase activities (16, 17). Except where indicated, cAMP accumulation was determined over a 3-min period following the addition of 10 µM forskolin. Cellular cAMP was determined by a binding assay kit (Amersham Pharmacia Biotech) after extraction with ice-cold 0.5 M trichloroacetic acid followed by washing (4 times) with water-saturated ether and neutralization with sodium bicarbonate. Values were normalized to total cellular protein (Coomassie Blue reagent, Pierce).

Measurements of [Ca2+]i and Mn2+ Quench-- Determinations of changes in [Ca2+]i and rates of Mn2+ quench used techniques modified from those previously described (18, 19). Briefly, cells were loaded with the fluorescent probe indo-1 by incubating with 4 µM indo-1/AM for 12 min, followed by washing (three times) in saline. Cells were then incubated for a further 30 min at 37 °C to allow for complete hydrolysis of the acetoxymethyl ester. [Ca2+]i was measured as described previously (18, 19) and recorded as the ratio of the emitted fluorescence, measured as photon counts, at 405 and 485 nm with excitation at 350 nm. Measurements of Mn2+ quench were as described previously (19) using the sum of the two emitted fluorescences adjusted so as to make the result Ca2+ insensitive. Data were normalized to the initial value recorded at the time of Mn2+ addition. In the experiments described here, both the [Ca2+]i and Mn2+ quench were determined as an average for small groups of cells (approximately 30-50), thereby overcoming the potential problems of uneven transfection.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Initially, to estimate the success and consistency of the transfection procedure, forskolin-stimulated cAMP accumulation was determined in the parental HEK293 cells and in HEK293 cells following transient transfection with the type VIII adenylyl cyclase construct (AC8-HEK cells). The data obtained indicated that the accumulation of cAMP in the presence of phosphodiesterase inhibitors was barely detectable in the HEK293 cells under control conditions (22.2 ± 1.4 pmol/mg protein) but rose to 490.4 ± 21.7 pmol/mg protein (n = 3) in the presence of 10 µM forskolin presumably reflecting the activity of endogenous adenylyl cyclases. Following transient transfection with the type VIII adenylyl cyclase, resting cAMP accumulation was 157.2 ± 23.5 pmol/mg protein and was stimulated approximately 15-fold to 2250.3 ± 345.8 pmol/mg (n = 7) in the presence of forskolin. This amounts to a 4.6-fold increase in forskolin-stimulated cAMP accumulation following transfection. These data represent the results of separate transfections and demonstrate that reasonably consistent levels of expression were obtained in each case.

The overall aim of the study was to compare the ability of arachidonate-activated and store-operated (capacitative) Ca2+ entry pathways to induce an activation of the transfected adenylyl cyclase. We chose the sarcoplasmic-endoplasmic reticulum calcium pump inhibitor thapsigargin as the agent to activate the capacitative entry of Ca2+. The use of thapsigargin and exogenous arachidonic acid to activate capacitative and noncapacitative Ca2+ entry, respectively, avoids the potential activation or generation of additional signaling moieties such as Galpha s, Galpha i, protein kinase C, and G protein beta gamma subunits, which are known to have type-specific effects on adenylyl cyclase activity (20). Examination of the overall [Ca2+]i responses induced in each case revealed that the addition of 250 nM thapsigargin to the AC8-HEK cells produced a [Ca2+]i signal that closely paralleled that produced by 8 µM exogenous arachidonic acid (Fig. 1). This [Ca2+]i signal comprised an initial increase to a peak value over the first approximately 150 s followed by a slow decline (equivalent to approximately 30% of the initial increase) over the succeeding 200 s. Comparison of the thapsigargin and arachidonic acid responses indicated a close similarity in the rate of the initial increase, peak values attained, and rate of subsequent slow decline. The only consistent difference was a somewhat more rapid onset of the rise in [Ca2+]i in the case of thapsigargin addition. These concentrations were subsequently used in all remaining experiments.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Comparison of the effect of thapsigargin and arachidonic acid on [Ca2+]i levels in AC8-HEK293. Cells loaded with indo-1 were exposed to either thapsigargin (250 nM) or arachidonic acid (8 µM) at the point indicated by an arrow. Changes in [Ca2+]i recorded as the 405/485 emission ratio were determined in a group of 30-50 cells as described under "Experimental Procedures." Typical responses are illustrated.

Changes in adenylyl cyclase activity during the period when [Ca2+]i rose to its maximum values were assessed by determining cAMP accumulation in the presence of phosphodiesterase inhibitors and forskolin during the first 3 min after the addition of either 8 µM arachidonic acid or 250 nM thapsigargin (Fig. 2). It can be seen that thapsigargin produced a greater than 2.5-fold stimulation of adenylate cyclase during this period. In marked contrast and despite the very similar rate and magnitude of the overall increase in [Ca2+]i, arachidonic acid failed to produce any significant increase in adenylyl cyclase activity. This inability of the arachidonic acid-induced changes in [Ca2+]i to effectively increase cAMP accumulation was not due to any independent inhibitory action of the fatty acid on the adenylyl cyclase activity as, in a separate series of experiments, simultaneous addition of 8 µM arachidonic acid to cells exposed to 250 nM thapsigargin had no significant effect on the ability of the latter to increase cAMP accumulation (7.75 ± 0.28 µmol/mg protein for thapsigargin alone compared with 7.08 ± 0.28 µmol/mg protein for thapsigargin in the presence of arachidonic acid, n = 5, p = 0.07).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   The effect of arachidonic acid and thapsigargin on forskolin-stimulated adenylyl cyclase activity in AC8-HEK293 cells. Cells were pretreated for 10 min with the phosphodiesterase inhibitors isobutylmethylxanthine and 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone. Where indicated, (solid bars) 10 µM forskolin (+F) together with 8 µM arachidonic acid (AA) or 250 nM thapsigargin (thaps) was added, and cellular cAMP accumulation was determined 3 min later. Values are mean ± S.E., n = 7 (6 for the thapsigargin + forskolin).

Despite the overall similarity in the [Ca2+]i changes, it is important to appreciate that there are marked differences in the origin of these changes in the two situations. In the case of thapsigargin, Ca2+ is initially released from intracellular stores as a result of inhibition of the sarcoplasmic-endoplasmic reticulum calcium pump on the store membranes (21). The resulting depletion of the intracellular stores subsequently activates Ca2+ entry via a capacitative mechanism of unknown nature. In contrast, we have previously shown that the increase in [Ca2+]i induced by exogenous arachidonic acid results entirely from an increased Ca2+ entry (10, 11). As stimulation of the type VIII adenylyl cyclase has been reported to be specifically dependent on Ca2+ entry via capacitative pathways (13) it was important to compare the effects of thapsigargin and arachidonic acid at a time when [Ca2+]i changes were specifically dependent on Ca2+ entry alone. Furthermore it is known that, both in the case of thapsigargin and exogenous arachidonic acid, activation of Ca2+ entry is rather slow to develop (11, 19). To examine the time course of the activation of Ca2+ entry in the experiments performed here, a Mn2+ quench protocol was employed on the AC8-HEK cells. Fig. 3 illustrates the response to the addition of 8 µM arachidonic acid. As can be seen, although an increase in the rate of Mn2+ quench could be detected approximately 1 min after the addition of arachidonic acid, maximal rates were not achieved until some 2 min later. A similar time course for the increase in the rate of Mn2+ quench was obtained with the addition of 250 nM thapsigargin (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Activation of Mn2+ quench by arachidonic acid in AC8-HEK293. Cells loaded with indo-1 and the fluorescence of an area containing 30-50 cells were recorded. 0.05 mM Mn2+ was added at the point indicated (open arrowhead) followed by arachidonic acid (8 µM) at the point indicated (arrow). Mn2+ quench was recorded as the adjusted total fluorescence (Ftot) as described under "Experimental Procedures" and normalized to the value at the point when Mn2+ was first added. A typical response is illustrated.

Based on these data we sought to examine the effects on adenylyl cyclase activity over the period 3-6 min after addition, at which time Ca2+ entry was at its maximum. Consistent with the reported specific dependence of the Ca2+-sensitive adenylyl cyclase on capacitative Ca2+ entry and with the above data on the rates of Mn2+ quench, examination of the thapsigargin-stimulated rate of cAMP accumulation during this period was somewhat higher (approximately 38%) than that seen during the first 3 min despite the observed decline in overall values of [Ca2+]i (Fig. 4). This indicates that activation of the adenylyl cyclase is independent of overall values of [Ca2+]i as reported previously. Furthermore, nominal removal of extracellular Ca2+ during this period completely obliterated the observed thapsigargin-induced stimulation in adenylyl cyclase activity (Fig. 4). This did not reflect an inhibitory effect of extracellular Ca2+ on the adenylyl cyclase as activities in the absence of thapsigargin were not significantly affected. This demonstrates that any possible contribution from Ca2+ release from intracellular stores can be ignored at this stage of the response.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 4.   Comparison of the effect of thapsigargin on forskolin-stimulated adenylyl cyclase activity in AC8-HEK293 cells during the first and second 3-min periods after addition and the effect of extracellular Ca2+. Cells were pretreated for 10 min with the phosphodiesterase inhibitors isobutylmethylxanthine and 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone prior to the addition of thapsigargin (thaps) (250 nM). Forskolin (+F) (10 µM) was added either together with the thapsigargin or 3 min later. Cellular cAMP accumulation was determined 3 min after the addition of the forskolin. In the Ca2+-free experiments, cells were maintained in nominally Ca2+-free saline (i.e. no added Ca2+) throughout. Values are mean ± S.E., n = 4 or 7 (for "normal Ca2+ 0-3 min").

Comparison of the effects of thapsigargin and of arachidonic acid on the adenylyl cyclase activity during this period of maximal increase in Ca2+ entry (3-6 min after addition) reveals that, once again, whereas thapsigargin induces a marked stimulation in activity (approximately 2.5-fold), arachidonic acid completely fails to have any influence on the adenylyl cyclase (Fig. 5A). Importantly, this observed inability of arachidonate-induced changes in [Ca2+]i to induce any stimulation of adenylyl cyclase activity was not because of a lower rate of Ca2+ entry during this period as comparison of the rates of Mn2+ quench induced by thapsigargin (250 nM) and exogenous arachidonic acid (8 µM) during the period 3-6 min after the addition clearly show that, in fact, the arachidonate-induced rates of Mn2+ quench were more than twice that seen during the same period after the addition of thapsigargin (Fig. 5B).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   A, the effect of arachidonic acid (AA) and thapsigargin (thaps) on forskolin (+F)-stimulated adenylyl cyclase activity in AC8-HEK293 cells during the period of maximum Ca2+ entry (3-6 min after addition). Cells were pretreated for 10 min with the phosphodiesterase inhibitors isobutylmethylxanthine and 4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone, and then forskolin (10 µM) was added 3 min after either arachidonic acid (8 µM) or thapsigargin (250 nM). Cellular cAMP accumulation was determined 3 min later. Values are mean ± S.E., n = 4. B, comparison of the maximal rates of Mn2+ quench induced by arachidonic acid (AA) and by thapsigargin in AC8-HEK293. Mn2+ quench was recorded (see Fig. 3 for details) over the period of 3-6 min after the addition of either thapsigargin (250 nM) or arachidonic acid (8 µM), and the rates were determined as percent of quench/min. Values are mean ± S.E., n = 5.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The data obtained allow us to assess the contributions of the various components of the induced changes in [Ca2+]i to the observed stimulation of the transfected type VIII adenylyl cyclase. The reported absence of endogenous Ca2+-stimulated adenylyl cyclases in HEK293 cells (22) means that the effects observed can be ascribed exclusively to the transfected type VIII adenylyl cyclase. A major influence of general [Ca2+]i levels on the adenylyl cyclase activity can be excluded by the failure of exogenously added arachidonic acid to affect adenylyl cyclase activities. Despite very similar changes in the overall [Ca2+]i values in the thapsigargin-treated and the arachidonate-treated cells, thapsigargin produces a marked stimulation of adenylyl cyclase activity yet no increase is seen in the arachidonate-treated cells. This is further confirmed by the fact that the thapsigargin-induced stimulation of activity is significantly higher in the second 3-min period after the addition despite the obvious decline in [Ca2+]i during the same period. Furthermore, during the second 3-min period after the addition of thapsigargin, we have shown that the continued high adenylyl cyclase activity is entirely dependent on the presence of extracellular Ca2+. This clearly excludes any possible contribution from Ca2+ released from stores, at least during this period of the response. Together, these data clearly demonstrate that, at least in the thapsigargin-treated cells during the second 3-min period after addition, the adenylyl cyclase is being stimulated specifically by the entry of Ca2+. As such, these data are consistent with previous reports that the Ca2+-stimulated type VIII adenylyl cyclase (13), as with other Ca2+-sensitive adenylyl cyclases, responds particularly to the Ca2+ entry component of the overall Ca2+ signal (12, 13, 23). However, in marked contrast, the adenylyl cyclase is entirely unresponsive to the Ca2+ entry activated by arachidonic acid. This is despite the fact that, at the respective concentrations used, the rate of Ca2+ entry activated by arachidonic acid would appear to be greater than twice that induced by thapsigargin.

In the previous reports examining the Ca2+-sensitive adenylyl cyclases in vivo, it has been clearly demonstrated that the endogenous type VI Ca2+-inhibited adenylyl cyclase of C6-2B glioma cells, as well as the type I and VIII Ca2+-stimulated adenylyl cyclases transiently transfected into HEK293 cells, respond specifically to entry via a capacitative pathway; an even more substantial but nonspecific entry induced by ionomycin fails to affect adenylyl cyclase activity (13, 14). A similar tight coupling between capacitative Ca2+ entry and the type III adenylyl cyclase has been reported as underlying the potentiation of adrenocorticotrophin-induced cAMP formation by angiotensin II (24) and in the sustained potentiation of isoproterenol-stimulated cAMP generation by carbachol in mouse parotid (25). In all cases, it has been suggested that this high degree of specificity reflects an intimate association and co-localization of the enzyme with the capacitative channel sites in the plasma membrane. Obviously, this tight association applies both to endogenous as well as to heterologously expressed adenylyl cyclases. Additional experiments by Fagan et al. (14) have shown that this association between the adenylyl cyclase and sites of capacitative Ca2+ entry does not involve the cytoskeleton, implying either some form of co-compartmentalization within the plasma membrane or a direct protein-protein interaction. The same authors also demonstrated that the activation of the adenylate cyclase was a direct consequence of the Ca2+ influx via the capacitative channel and not to any conformational change associated with the channel opening. Given this demonstrated intimate spatial relationship between capacitative Ca2+ entry sites and the adenylyl cyclase, the complete failure of the Ca2+ entry induced by arachidonic acid to produce any change in adenylyl cyclase activity clearly demonstrates that the arachidonate-induced Ca2+ entry channel must be an entirely distinct entity from that responsible for capacitative entry.

    ACKNOWLEDGEMENTS

We thank Dr. Dermot Cooper of the University of Colorado for generously providing us with the rat type VIII adenylyl cyclase cDNA plasmid.

    FOOTNOTES

* This work was supported by National Institute of General Medical Sciences Grant GM 40457.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pharmacology and Physiology, Box 711, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 716-275-2076; Fax: 716-244-9283; E-mail: tshut@pharmacol.rochester.edu.

    ABBREVIATIONS

The abbreviation used is: [Ca2+]i, intracellular free calcium ion concentration.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Putney, J. W., Jr. (1986) Cell Calcium 7, 1-12[CrossRef][Medline] [Order article via Infotrieve]
2. Putney, J. W., Jr. (1990) Cell Calcium 11, 611-624[CrossRef][Medline] [Order article via Infotrieve]
3. Shuttleworth, T. J., and Thompson, J. L. (1996) Biochem J. 316, 819-824
4. Shuttleworth, T. J. (1999) Cell Calcium 25, 237-246[CrossRef][Medline] [Order article via Infotrieve]
5. Kawanishi, T., Blank, L. M., Harootunian, A. T., Smith, M. T., and Tsien, R. Y. (1989) J. Biol. Chem. 264, 12859-12866[Abstract/Free Full Text]
6. Rooney, T. A., Sass, E. J., and Thomas, A. P. (1990) J. Biol. Chem. 265, 10792-10796[Abstract/Free Full Text]
7. Girard, S., and Clapham, D. (1993) Science 260, 229-232[Abstract/Free Full Text]
8. Shuttleworth, T. J., and Thompson, J. L. (1996) Biochem. J. 313, 815-819
9. Bootman, M. D., Young, K. W., Young, J. M., Moreton, R. B., and Berridge, M. J. (1996) Biochem. J. 314, 347-354
10. Shuttleworth, T. J. (1996) J. Biol. Chem. 271, 21720-21725[Abstract/Free Full Text]
11. Shuttleworth, T. J., and Thompson, J. L. (1998) J. Biol. Chem. 273, 32636-32643[Abstract/Free Full Text]
12. Cooper, D. M. F., Karpen, J. W., Fagan, K. A., and Mons, N. E. (1998) Adv. Second Messenger Phosphoprotein Res. 32, 23-51[Medline] [Order article via Infotrieve]
13. Fagan, K. A., Mahey, R., and Cooper, D. M. F. (1996) J. Biol. Chem. 271, 12438-12444[Abstract/Free Full Text]
14. Fagan, K. A., Mons, N., and Cooper, D. M. F. (1998) J. Biol. Chem. 273, 9297-9305[Abstract/Free Full Text]
15. Chen, C., and Okayama, H. (1987) Mol. Cell. Biol. 7, 2745-2752[Abstract/Free Full Text]
16. Meeker, R. B., and Harden, T. K. (1982) Mol. Pharmacol. 22, 310-319[Abstract]
17. Erneux, C., Van Sande, J., Miot, F., Cochaux, P., Decoster, C., and Dumont, J. E. (1985) Mol. Cell. Endocrinol. 43, 123-134[CrossRef][Medline] [Order article via Infotrieve]
18. Martin, S. C., and Shuttleworth, T. J. (1994) FEBS Lett. 352, 32-36[CrossRef][Medline] [Order article via Infotrieve]
19. Shuttleworth, T. J. (1994) Cell Calcium 15, 457-466[CrossRef][Medline] [Order article via Infotrieve]
20. Sunahara, R. K., Dessauer, C. W., and Gilman, A. G. (1996) Annu. Rev. Pharmacol. Toxicol. 36, 461-480[CrossRef][Medline] [Order article via Infotrieve]
21. Thastrup, O. (1990) Agents Actions 29, 8-15[CrossRef][Medline] [Order article via Infotrieve]
22. Choi, E-J., Wong, S. T., Hinds, T. R., and Storm, D. R. (1992) J. Biol. Chem. 267, 12440-12442[Abstract/Free Full Text]
23. Chiono, M., Mahey, R., Tate, G., and Cooper, D. M. F. (1995) J. Biol. Chem. 270, 1149-1155[Abstract/Free Full Text]
24. Burnay, M. M., Vallotton, M. B., Capponi, A. M., and Rossier, M. F. (1998) Biochem. J. 330, 21-27
25. Watson, E. L., Wu, Z., Jacobson, K. L., Storm, D. R., Singh, J. C., and Ott, S. M. (1998) Am. J. Physiol. 274, C557-C565[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
A. B. Parekh
Ca2+ microdomains near plasma membrane Ca2+ channels: impact on cell function
J. Physiol., July 1, 2008; 586(13): 3043 - 3054.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Kolsch, P. G. Charest, and R. A. Firtel
The regulation of cell motility and chemotaxis by phospholipid signaling
J. Cell Sci., March 1, 2008; 121(5): 551 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Borges, S. Lindstrom, C. Walters, A. Warrier, and M. Wilson
Discrete influx events refill depleted Ca2+ stores in a chick retinal neuron
J. Physiol., January 15, 2008; 586(2): 605 - 626.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev, July 1, 2007; 87(3): 965 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. C. Maia, C. A. Culver, and S. M. Laster
Evidence against Calcium as a Mediator of Mitochondrial Dysfunction during Apoptosis Induced by Arachidonic Acid and Other Free Fatty Acids
J. Immunol., November 1, 2006; 177(9): 6398 - 6404.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Singaravelu, C. Lohr, and J. W. Deitmer
Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes.
J. Neurosci., September 13, 2006; 26(37): 9579 - 9592.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. C. L. Martin and D. M. F. Cooper
Capacitative and 1-Oleyl-2-acetyl-sn-glycerol-Activated Ca2+ Entry Distinguished Using Adenylyl Cyclase Type 8
Mol. Pharmacol., August 1, 2006; 70(2): 769 - 777.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
R. Zur Nieden and J. W. Deitmer
The Role of Metabotropic Glutamate Receptors for the Generation of Calcium Oscillations in Rat Hippocampal Astrocytes In Situ
Cereb Cortex, May 1, 2006; 16(5): 676 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
O. Mignen, C. Brink, A. Enfissi, A. Nadkarni, T. J. Shuttleworth, D. R. Giovannucci, and T. Capiod
Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells
J. Cell Sci., December 1, 2005; 118(23): 5615 - 5623.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Dyer, Y. Liu, I. P. de la Huerga, and C. W. Taylor
Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release
J. Biol. Chem., March 11, 2005; 280(10): 8936 - 8944.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
T. J. Shuttleworth, J. L. Thompson, and O. Mignen
ARC Channels: A Novel Pathway for Receptor-Activated Calcium Entry
Physiology, December 1, 2004; 19(6): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wicher, S. Messutat, C. Lavialle, and B. Lapied
A New Regulation of Non-capacitative Calcium Entry in Insect Pacemaker Neurosecretory Neurons: INVOLVEMENT OF ARACHIDONIC ACID, NO-GUANYLYL CYCLASE/cGMP, AND cAMP
J. Biol. Chem., November 26, 2004; 279(48): 50410 - 50419.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Goraya, N. Masada, A. Ciruela, and D. M. F. Cooper
Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1A
J. Biol. Chem., September 24, 2004; 279(39): 40494 - 40504.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Liu, Z. Liu, S. Chuai, and X. Shen
Phospholipase C and phosphatidylinositol 3-kinase signaling are involved in the exogenous arachidonic acid-stimulated respiratory burst in human neutrophils
J. Leukoc. Biol., September 1, 2003; 74(3): 428 - 437.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. M. Tribe, P. Moriarty, A. Dalrymple, A. A. Hassoni, and L. Poston
Interleukin-1{beta} Induces Calcium Transients and Enhances Basal and Store Operated Calcium Entry in Human Myometrial Smooth Muscle
Biol Reprod, May 1, 2003; 68(5): 1842 - 1849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Szabadkai, A. M. Simoni, and R. Rizzuto
Mitochondrial Ca2+ Uptake Requires Sustained Ca2+ Release from the Endoplasmic Reticulum
J. Biol. Chem., April 18, 2003; 278(17): 15153 - 15161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Smani, S. I. Zakharov, E. Leno, P. Csutora, E. S. Trepakova, and V. M. Bolotina
Ca2+-independent Phospholipase A2 Is a Novel Determinant of Store-operated Ca2+ Entry
J. Biol. Chem., March 28, 2003; 278(14): 11909 - 11915.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Mignen, J. L. Thompson, and T. J. Shuttleworth
Ca2+ Selectivity and Fatty Acid Specificity of the Noncapacitative, Arachidonate-regulated Ca2+ (ARC) Channels
J. Biol. Chem., March 14, 2003; 278(12): 10174 - 10181.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. K. Monteilh-Zoller, M. C. Hermosura, M. J.S. Nadler, A. M. Scharenberg, R. Penner, and A. Fleig
TRPM7 Provides an Ion Channel Mechanism for Cellular Entry of Trace Metal Ions
J. Gen. Physiol., December 30, 2002; 121(1): 49 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. D. Bootman, P. Lipp, and M. J. Berridge
The organisation and functions of local Ca2+ signals
J. Cell Sci., March 8, 2002; 114(12): 2213 - 2222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. E. Smith, C. Gu, K. A. Fagan, B. Hu, and D. M. F. Cooper
Residence of Adenylyl Cyclase Type 8 in Caveolae Is Necessary but Not Sufficient for Regulation by Capacitative Ca2+ Entry
J. Biol. Chem., February 15, 2002; 277(8): 6025 - 6031.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Mignen and T. J. Shuttleworth
IARC, a Novel Arachidonate-regulated, Noncapacitative Ca2+ Entry Channel
J. Biol. Chem., March 24, 2000; 275(13): 9114 - 9119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Osterhout and T. J. Shuttleworth
A Ca2+-independent Activation of a Type IV Cytosolic Phospholipase A2 Underlies the Receptor Stimulation of Arachidonic Acid-dependent Noncapacitative Calcium Entry
J. Biol. Chem., March 10, 2000; 275(11): 8248 - 8254.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Fagan, K. E. Smith, and D. M. F. Cooper
Regulation of the Ca2+-inhibitable Adenylyl Cyclase Type VI by Capacitative Ca2+ Entry Requires Localization in Cholesterol-rich Domains
J. Biol. Chem., August 18, 2000; 275(34): 26530 - 26537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Fagan, R. A. Graf, S. Tolman, J. Schaack, and D. M. F. Cooper
Regulation of a Ca2+-sensitive Adenylyl Cyclase in an Excitable Cell. ROLE OF VOLTAGE-GATED VERSUS CAPACITATIVE Ca2+ ENTRY
J. Biol. Chem.,